SSSari Suomela

Sari Suomela

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sari Suomela has a total of 64 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Occupational Allergic Contact Dermatitis Caused by Cyclohexyl Diethanolamine in a Metalworking Fluid

    by Maria Pesonen, Sari Suomela, Katri Suuronen

  • Open Access

    Isothiazolinones in Disposable Rubber Gloves—Results of Chemical Analysis

    by Katri Suuronen, Katriina Ylinen, Sari Suomela, Maria Pesonen

    Background: Contact allergy to benzisothiazolinone (BIT) has increased in recent years, but exposure to it is not always found. It's important to know whether the gloves might be an isothiazolinone source especially in patients with symptoms from gloves and isothiazolinone contact allergy with or without allergy to rubber chemicals. Objectives: To present results of chemical analysis of isothiazolinones in disposable rubber gloves of patients in an occupational dermatology clinic. Methods: We went through our chemical analysis record from 2018–2025 and identified isothiazolinone analyses done from disposable rubber gloves. The chemical analysis of glove extracts was done by liquid chromatography‐mass spectrometry (LC–MS). We screened the respective patients' files and collected information on their occupation, glove usage, patch test reactions as well as basic information on their hand eczema. Results: We discovered BIT in 30/54 (60%) analysed gloves (27 nitrile rubber gloves, 2 neoprene rubber gloves and 1 natural rubber glove) in concentrations of 0.3–73.7 ppm (mean 12.7 ppm, median 4.2 ppm). Methylisothiazolinone (MI) was found in solitary gloves in small concentrations. Isothiazolinone‐containing gloves were samples from altogether 21 patients, and six of them had several gloves that contained isothiazolinones. Many patients had also other isothiazolinone sources at work or at home. Conclusions: Disposable rubber gloves are a possible BIT source. Several gloves contained BIT in a concentration that may be enough to induce contact allergy when gloves are used frequently.


  • Open Access

    Nine years of patch testing with isocyanates in a clinic of occupational dermatology

    by Kristiina Aalto‐Korte, Maria Pesonen, Sari Suomela, Katri Suuronen

    Background: Isocyanates are used as starting materials of polyurethane (PU) products. They are relatively important occupational skin sensitizers.Objectives: To analyse results of a large isocyanate patch test series of 19 isocyanate test substances and 4,4′‐diaminodiphenylmethane (MDA), a marker of 4,4′‐diphenylmethane diisocyanate (MDI) hypersensitivity.Methods: Test files were screened for positive reactions in the isocyanate series. Patients with positive reactions were analysed for occupation, exposure and diagnosis.Results: In 2010–2019, 53 patients had positive reactions in the series (16% of 338 patients tested). MDA, the well‐established screening substance for MDI allergy, was positive in 30 patients, an in‐house monomeric MDI test substance in 23 patients and 3 different polymeric MDI test substances in 19–21 patients. We diagnosed 16 cases of occupational allergic contact dermatitis (OACD) from MDI including 3 pipe reliners. Hexamethylene‐1,6‐diisocyanate (HDI) oligomers in paint hardeners caused 5 cases of OACD, more cases than 2,4‐toluene diisocyanate (TDI; n = 3) and isophorone diisocyanate (IPDI; n = 1) put together.Conclusions: In contrast to previous studies, polymeric MDI test substances were not superior to a monomeric MDI. Pipe reliners may get sensitised not only by epoxy products and acrylates but also by MDI in hardeners of PU pipe coatings. HDI oligomers were the second most important causes of OACD after MDI.


  • Open Access

    Severely compromised supply of patch test allergens in Europe hampers adequate diagnosis of occupational and non‐occupational contact allergy. A European Society of Contact Dermatitis (ESCD), European Academy of Allergy and Clinical Immunology (EAACI), European Academy of Dermatology and Venereology (EADV) task forces ‘Contact Dermatitis’ and ‘Occupational Skin Disease’ position paper

    by Swen Malte John, Andreas Bonertz, Julia Zimmer, Olivier Aerts, Andrea Bauer, Maria Bova, Richard Brans, Stefano Del Giacco, Heinrich Dickel, Monica Corazza, et al.

    Patch testing is the only clinically applicable diagnostic method for Type IV allergy. The availability of Type IV patch test (PT) allergens in Europe, however, is currently scarce. This severely compromises adequate diagnostics of contact allergy, leading to serious consequences for the affected patients. Against this background, the European Society of Contact Dermatitis (ESCD) has created a task force (TF) (i) to explore the current availability of PT substances in different member states, (ii) to highlight some of the unique characteristics of Type IV vs. other allergens and (iii) to suggest ways forward to promote and ensure availability of high‐quality patch testing substances for the diagnosis of Type IV allergies throughout Europe. The suggestions of the TF on how to improve the availability of PT allergens are supported by the ESCD, the European Academy of Allergy and Clinical Immunology, and the European Academy of Dermatology and Venereology and intend to provide potential means to resolve the present medical crisis.


  • Open Access

    Allergic contact dermatitis caused by colophonium in resin creams

    by Susan Lievonen, Maria Pesonen, Sari Suomela


  • Open Access

    Occupational contact allergy to benzyl alcohol in epoxy hardeners

    by Maria Pesonen, Katriina Ylinen, Sari Suomela, Katri Suuronen


  • Open Access

    Occupational contact urticaria due to diethylphthalate in hand sanitizers

    by Sari Suomela, Katri Suuronen


  • Open Access

    Characterization of patients with occupational allergy to two new epoxy hardener compounds

    by Sari Suomela, Maria Pesonen, Katriina Ylinen, Kristiina Aalto‐Korte, Katri Suuronen

    Background: The practical importance of two recently described epoxy hardener allergens—1,3‐benzenedimethanamine, N‐(2‐phenylethyl) derivatives (1,3‐BDMA‐D) and hydrogenated formaldehyde benzenamine polymer (FBAP)—as occupational allergens remains to be defined.Objectives: To describe patients diagnosed at the Finnish Institute of Occupational Health (FIOH) with positive reactions to 1,3‐BDMA‐D or FBAP.Methods: We searched FIOH's patch‐test files from January 2017 to December 2020 for patients examined due to suspected occupational contact allergy to epoxy compounds. We analyzed the patch‐test results and sources of exposure to various epoxy hardeners and focused on occupations, symptoms, and the sources of exposure to 1,3‐BDMA‐D and FBAP.Results: During the study period, 102 patients were examined at FIOH for suspected occupational contact allergy to epoxy compounds. Of these, 19 (19%) were diagnosed with contact allergy to 1,3‐BDMA‐D (n = 10) or FBAP (n = 12). The largest occupational group was sewage pipe reliners (n = 8). Seven different hardener products contained FBAP, whereas 1,3‐BDMA‐D was present in only one hardener used by spray painters.Conclusions: A substantial number of patients with suspected occupational epoxy resin system allergy tested positive to in‐house test substances of 1,3‐BDMA‐D and/or FBAP.


  • Open Access

    Machine-learning–driven biomarker discovery for the discrimination between allergic and irritant contact dermatitis

    by Vittorio Fortino, Lukas Wisgrill, Paulina Werner, Sari Suomela, Nina Linder, Erja Jalonen, Alina Suomalainen, Veer Marwah, Mia Kero, Maria Pesonen, et al.

    Contact dermatitis tremendously impacts the quality of life of suffering patients. Currently, diagnostic regimes rely on allergy testing, exposure specification, and follow-up visits; however, distinguishing the clinical phenotype of irritant and allergic contact dermatitis remains challenging. Employing integrative transcriptomic analysis and machine-learning approaches, we aimed to decipher disease-related signature genes to find suitable sets of biomarkers. A total of 89 positive patch-test reaction biopsies against four contact allergens and two irritants were analyzed via microarray. Coexpression network analysis and Random Forest classification were used to discover potential biomarkers and selected biomarker models were validated in an independent patient group. Differential gene-expression analysis identified major gene-expression changes depending on the stimulus. Random Forest classification identified CD47, BATF, FASLG, RGS16, SYNPO, SELE, PTPN7, WARS, PRC1, EXO1, RRM2, PBK, RAD54L, KIFC1, SPC25, PKMYT, HISTH1A, TPX2, DLGAP5, TPX2, CH25H, and IL37 as potential biomarkers to distinguish allergic and irritant contact dermatitis in human skin. Validation experiments and prediction performances on external testing datasets demonstrated potential applicability of the identified biomarker models in the clinic. Capitalizing on this knowledge, novel diagnostic tools can be developed to guide clinical diagnosis of contact allergies. Significance Contact dermatitis is an inflammatory skin disorder that arises from direct skin contact with irritants or allergens. Representing over 90% of occupational skin disorders, it has a considerable socioeconomic impact, and patients suffering from contact dermatitis can develop a notable physical handicap. Current diagnostic regimes rely on allergy testing, exposure specification, and follow-up visits. However, distinguishing the clinical phenotype of irritant and allergic contact dermatitis, which is important for appropriate therapeutic strategies, remains challenging. This study identifies and validates biomarkers to distinguish allergic and irritant contact dermatitis in human skin, to be used for the development of novel diagnostic methods and to guide clinical diagnosis.


  • Allergic reactions to lower concentrations of nickel sulfate and formaldehyde often appear later than reactions to higher concentrations

    by Kristiina Aalto‐Korte, Sari Suomela, Maria Pesonen

    Background: A late‐appearing patch test reaction may be a sign of active sensitization or represent a delayed elicitation reaction.Objectives: To retrospectively study the effect of concentration on the time course of allergic reactions to routine concentration dilution series of formaldehyde and nickel sulfate.Methods: We tested concentration dilution series of 2%, 1%, 0.32% and 0.1% formaldehyde and 5%, 1.6%, 0.5% and 0.16% nickel sulfate, respectively. The last readings were performed on day 4 to day 6. We included patients with allergic reactions to either of the two lowest concentrations in each dilution series and whose tests had been read three times.Results: Forty‐two nickel‐allergic and 23 formaldehyde‐allergic patients fulfilled the inclusion criteria. In 26 (62%) of the nickel‐sensitive patients, reactions to lower concentrations appeared later than reactions to the highest concentration. Of the formaldehyde‐sensitive patients, 17 (74%) developed one or two allergic reactions to lower concentrations later than reactions to the highest concentration, and one (4%) patient developed allergic reactions to lower concentrations sooner than a reaction to the highest concentration. The remaining patients showed all allergic reactions at the same reading.Conclusions: In these selected, relatively strongly sensitized patients, allergic reactions to lower concentrations quite regularly appeared later than reactions to higher concentrations.